Hearing Aid BTE RIC denied as duplicate or overlapping therapy by Humana?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for hearing aid bte ric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Hearing Aid BTE RIC
## Why Humana Denies Behind-the-Ear / Receiver-in-Canal Hearing Aids as Duplicate Therapy
Humana may deny a behind-the-ear (BTE) or receiver-in-canal (RIC) hearing aid on duplicate-therapy grounds when the member has received a hearing aid within a benefit period that Humana has not yet considered closed, or when records suggest the member is using another assistive hearing device that Humana's reviewer characterizes as serving the same function. This denial can also arise when a replacement device is requested before the plan's replacement-cycle interval has elapsed.
## Why This Denial Is Appealable
A duplicate-therapy denial is appealable when the existing device is (a) no longer functional, (b) no longer adequate for the patient's current hearing loss, or (c) a clinically different device type that serves a different audiological purpose than the one now being prescribed. Hearing loss is progressive, and a device fitted for an earlier degree of loss may be genuinely insufficient for the patient's current audiogram — that clinical change is the foundation of the appeal. Under ACA §2719, non-grandfathered plans must provide internal appeal rights and external IRO review. ERISA §503 applies to employer plans. The external-review window is approximately four months from the denial; expedited review is available for urgent situations.
## The Appeal Process
1. Obtain the denial rationale in writing. Humana must specify which prior device or therapy it considers duplicative and the benefit-period dates it is relying on. 2. File a Level 1 internal appeal demonstrating that the prior device is inadequate for the patient's current audiological status or that no functional equivalent is in service. 3. Include an audiologist's clinical comparison distinguishing the prior device from the requested BTE/RIC in terms of fitting range, features, and clinical indication. 4. Proceed to Level 2 internal appeal or external IRO review if the internal appeal is denied.
## Documentation to Gather
- Current audiogram: A recent audiological evaluation showing the patient's current hearing thresholds — the foundation for demonstrating that the previously covered device no longer meets clinical need.
- Prior device records: Dates of prior fittings, device model, and the audiogram at the time of fitting, to show the clinical change since then.
- Device-inadequacy documentation: Audiologist's note explaining why the prior device cannot be adjusted or reprogrammed to address the current hearing loss.
- Malfunction or loss documentation: If the prior device is broken or lost, a written statement from the audiologist or a repair-facility assessment.
- Medical-necessity letter: Audiologist or ENT letter explaining why the specific BTE/RIC configuration is medically appropriate for this patient's current hearing profile.
## Criteria-Mapping Structure
Obtain Humana's hearing-aid coverage policy. For each criterion used to support the duplicate-therapy denial:
| Humana Policy Criterion / Denial Basis | Patient-Specific Rebuttal | |---|---| | [Quote criterion or denial rationale verbatim] | [Specific audiogram date, finding, and audiologist's clinical interpretation] |
Attach the current and prior audiograms side by side as exhibits to make the clinical progression immediately visible to the reviewer.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →